Search Results - "Verhoeff, J"

Impact of the COVID-19 pandemic on quality of life and emotional wellbeing in patients with bone metastases treated with radiotherapy: a prospective cohort study by Bartels, M. M. T. J., Gal, R., van der Velden, J. M., Verhoeff, J. J. C., Verlaan, J. J., Verkooijen, H. M.

“…Implementation of COVID-19 measures may have induced concerns about access and quality of health care for cancer patients with bone metastases, and it may have…”
Get full text

First experimental exploration of real-time cardiorespiratory motion management for future stereotactic arrhythmia radioablation treatments on the MR-linac by Akdag, O, Borman, P T S, Woodhead, P, Uijtewaal, P, Mandija, S, Van Asselen, B, Verhoeff, J J C, Raaymakers, B W, Fast, M F

“…Stereotactic arrhythmia radioablation (STAR) is a novel, non-invasive treatment for refractory ventricular tachycardia (VT). The VT isthmus is subject to both…”
Get more information

Ischemic stroke after radiation therapy for pituitary adenomas: a systematic review by van Westrhenen, A., Muskens, I. S., Verhoeff, J. J. C., Smith, T. R. S., Broekman, M. L. D.

“…Radiation therapy is widely used for the treatment of residual and recurrent pituitary adenomas and proved to effectively control tumor growth. However, it is…”
Get full text

Individual treatment effect estimation in the presence of unobserved confounding using proxies: a cohort study in stage III non-small cell lung cancer by van Amsterdam, Wouter A. C., Verhoeff, Joost. J. C., Harlianto, Netanja I., Bartholomeus, Gijs A., Puli, Aahlad Manas, de Jong, Pim A., Leiner, Tim, van Lindert, Anne S. R., Eijkemans, Marinus J. C., Ranganath, Rajesh

“…Randomized Controlled Trials (RCT) are the gold standard for estimating treatment effects but some important situations in cancer care require treatment effect…”
Get full text

Patient vulnerability in stereotactic arrhythmia radioablation (STAR): a preliminary ethical appraisal from the STOPSTORM.eu consortium by Botrugno, Carlo, Crico, Chiara, Iori, Mauro, Blanck, Oliver, Blamek, Slawomir, Postema, Pieter G., Quesada, Aurelio, Pruvot, Etienne, Verhoeff, Joost J. C., De Panfilis, Ludovica

“…This preliminary ethical appraisal from the STOPSTORM.eu consortium is meant to raise critical points that clinicians administering stereotactic arrhythmia…”
Get full text

From algorithms to action: improving patient care requires causality by van Amsterdam, Wouter A C, de Jong, Pim A, Verhoeff, Joost J C, Leiner, Tim, Ranganath, Rajesh

“…In cancer research there is much interest in building and validating outcome prediction models to support treatment decisions. However, because most outcome…”
Get full text

Bevacizumab and dose-intense temozolomide in recurrent high-grade glioma by Verhoeff, J.J.C., Lavini, C., van Linde, M.E., Stalpers, L.J.A., Majoie, C.B.L.M., Reijneveld, J.C., van Furth, W.R., Richel, D.J.

“…Angiogenesis inhibition is a rational treatment strategy for high-grade glioma (HGG). Combined antiangiogenic therapy and chemotherapy could be beneficial,…”
Get full text

Cognitive impairments are independently associated with shorter survival in diffuse glioma patients by van Kessel, Emma, Huenges Wajer, Irene M. C., Ruis, Carla, Seute, Tatjana, Fonville, Susanne, De Vos, Filip Y. F. L., Verhoeff, Joost J. C., Robe, Pierre A., van Zandvoort, Martine J. E., Snijders, Tom J.

“…Background Diffuse gliomas (WHO grade II–IV) are progressive primary brain tumors with great variability in prognosis. Cognitive deficits are of important…”
Get full text

Stereotactic radiosurgery versus whole-brain radiotherapy after intracranial metastasis resection: a systematic review and meta-analysis by Lamba, Nayan, Muskens, Ivo S, DiRisio, Aislyn C, Meijer, Louise, Briceno, Vanessa, Edrees, Heba, Aslam, Bilal, Minhas, Sadia, Verhoeff, Joost J C, Kleynen, Catharina E, Smith, Timothy R, Mekary, Rania A, Broekman, Marike L

“…In patients with one to three brain metastases who undergo resection, options for post-operative treatments include whole-brain radiotherapy (WBRT) or…”
Get full text

Eliminating biasing signals in lung cancer images for prognosis predictions with deep learning by van Amsterdam, W. A. C., Verhoeff, J. J. C., de Jong, P. A., Leiner, T., Eijkemans, M. J. C.

“…Deep learning has shown remarkable results for image analysis and is expected to aid individual treatment decisions in health care. Treatment recommendations…”
Get full text

High-precision stereotactic irradiation for focal drug-resistant epilepsy versus standard treatment: a randomized waitlist-controlled trial (the PRECISION trial) by Zegers, C M L, Swinnen, A, Roumen, C, Hoffmann, A L, Troost, E G C, van Asch, C J J, Brandts, L, Compter, I, Dieleman, E M T, Dijkstra, J B, Granzier, M, Hendriks, M, Hofman, P, Houben, R M A, Ramaekers, B, Ronner, H E, Rouhl, R P W, van der Salm, S, Santegoeds, R G C, Verhoeff, J J, Wagner, G L, Zwemmer, J, Schijns, Oemg, Colon, A J, Eekers, D B P

“…The standard treatment for patients with focal drug-resistant epilepsy (DRE) who are not eligible for open brain surgery is the continuation of anti-seizure…”
Get full text

Cancer Stem Cell Tumor Model Reveals Invasive Morphology and Increased Phenotypical Heterogeneity by SOTTORIVA, Andrea, VERHOEFF, Joost J. C, BOROVSKI, Tijana, MCWEENEY, Shannon K, NAUMOV, Lev, MEDEMA, Jan Paul, SLOOT, Peter M. A, VERMEULEN, Louis

“…The recently developed concept of cancer stem cells (CSC) sheds new light on various aspects of tumor growth and progression. Here, we present a mathematical…”
Get full text

Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma by Svendsen, Agnete, Verhoeff, Joost J. C., Immervoll, Heike, Brøgger, Jan C., Kmiecik, Justyna, Poli, Aurelie, Netland, Inger A., Prestegarden, Lars, Planagumà, Jesús, Torsvik, Anja, Kjersem, Anneli Bohne, Sakariassen, Per Ø., Heggdal, Jan I., Van Furth, Wouter R., Bjerkvig, Rolf, Lund-Johansen, Morten, Enger, Per Ø., Felsberg, Joerg, Brons, Nicolaas H. C., Tronstad, Karl J., Waha, Andreas, Chekenya, Martha

“…Glioblastoma (GBM) is a highly aggressive brain tumour, where patients respond poorly to radiotherapy and exhibit dismal survival outcomes. The mechanisms of…”
Get full text

The impact of etiology in lesion-symptom mapping – A direct comparison between tumor and stroke by van Grinsven, E.E., Smits, A.R., van Kessel, E., Raemaekers, M.A.H., de Haan, E.H.F., Huenges Wajer, I.M.C., Ruijters, V.J., Philippens, M.E.P., Verhoeff, J.J.C., Ramsey, N.F., Robe, P.A.J.T., Snijders, T.J., van Zandvoort, M.J.E.

“…•We directly compared LSM in brain tumors and ischemic stroke patients.•Known neuro-anatomical correlates were found, but differed between…”
Get full text

Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the 'TOaSTT' database by Kroeze, Stephanie G C, Schaule, Jana, Fritz, Corinna, Kaul, David, Blanck, Oliver, Kahl, Klaus H, Roeder, Falk, Siva, Shankar, Verhoeff, Joost J C, Adebahr, Sonja, Schymalla, Markus M, Glatzer, Markus, Szuecs, Marcella, Geier, Michael, Skazikis, Georgios, Sackerer, Irina, Lohaus, Fabian, Eckert, Franziska, Guckenberger, Matthias

“…Metastasis directed treatment (MDT) is increasingly performed with the attempt to improve outcome in non-small cell lung cancer (NSCLC) patients receiving…”
Get full text

Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma by Kroeze, Stephanie G.C., Fritz, Corinna, Schaule, Jana, Siva, Shankar, Kahl, Klaus H., Sundahl, Nora, Blanck, Oliver, Kaul, David, Adebahr, Sonja, Verhoeff, Joost J.C., Skazikis, Georgios, Roeder, Falk, Geier, Michael, Eckert, Franziska, Guckenberger, Matthias

“…Objectives To evaluate the safety and efficacy of stereotactic radiotherapy (SRT) in patients with metastatic renal cell carcinoma (mRCC) concurrently…”
Get full text

Impact of the COVID-19 crisis on imaging in oncological trials by Deroose, Christophe M., Lecouvet, Frédéric E., Collette, Laurence, Oprea-Lager, Daniela E., Kunz, Wolfgang G., Bidaut, Luc, Verhoeff, Joost J. C., Caramella, Caroline, Lopci, Egesta, Tombal, Bertrand, de Geus-Oei, Lioe-Fee, Fournier, Laure, Smits, Marion, deSouza, Nandita M.

Get full text

Non-Small-Cell Lung Cancer Patients with a High Predicted Risk of Irradical Resection: Can Chemoradiotherapy Offer Similar Survival? by van Joolingen, W. Hugo, Rasing, Marnix J. A., Peters, Max, van Lindert, Anne S. R., de Heer, Linda M., Aarts, Mieke J., Verhoeff, Joost J. C., van Rossum, Peter S. N.

“…Purpose Irradical resection of non-small-cell lung cancer (NSCLC) is a detrimental prognostic factor. Recently, Rasing et al. presented an internationally…”
Get full text

ASO Visual Abstract: Non-small Cell Lung Cancer Patients with a High Predicted Risk of Irradical Resection—can Chemoradiotherapy Offer Similar Survival? by van Joolingen, W. Hugo, Rasing, Marnix J. A., Peters, Max, van Lindert, Anne S. R., de Heer, Linda M., Aarts, Mieke J., Verhoeff, Joost J. C., van Rossum, Peter S. N.

Get full text

Long-term outcomes of two ablation techniques for treatment of radio-recurrent prostate cancer by Nair, Shiva M., Peters, Max, Kurver, Piet, Lavi, Arnon, Verhoeff, Joost J. C., van der Voort van Zyp, Jochem R. N., van Son, Marieke J., Chin, Joseph L.

“…Background In men with recurrence of prostate cancer post radiation therapy, further treatment remains a challenge. The default salvage option of…”
Get full text